A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SPF / S-phase fraction

[Related PubMed/MEDLINE]
Total Number of Papers: 484
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SPF  (>> Co-occurring Abbreviation)
Long Form:   S-phase fraction
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity. CRM1, IHC, PAC
2017 Correlation between ploidy status using flow cytometry and nucleolar organizer regions in benign and malignant epithelial odontogenic tumors. AB, ABC, AgNORs, CCOC, FCM, FFPE, KCOT
2017 DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. ---
2017 Leukocyte-reduced platelet-rich plasma stimulates the in vitro proliferation of adipose-tissue derived mesenchymal stem cells depending on PDGF signaling. ASCs, FCS, PDGF, PRP
2013 A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial. HR, PR
2013 DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients. DFS, DSS, IDC
2013 Effects of DNA ploidy and S-phase fraction on fluorine-18 FDG uptake of primary breast cancer lesions. CT, DTP, FCM, PET, RI
2013 Identification of intermediate risk breast cancer patients with 1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis. BCS, ccCK18, DRFS, PI
2013 Spontaneously occurring micronuclei in infiltrating ductal carcinoma of breast: a potential biomarker for aggressive phenotype detection? CIN, DI, FNAC, MN
10  2012 Diagnostic, predictive and prognostic verification of DNA flow cytometric measurements performed at diagnosis for non-Hodgkin's lymphoma adult patients. ---
11  2012 Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer. ---
12  2012 Prognostic significance of DNA image cytometry in Libyan breast cancer. ---
13  2012 Prognostic significance of ploidy and S-phase fraction in primary intraoral squamous cell carcinoma and their corresponding metastatic lymph nodes. DFS, FCM, FFPE, OSCC
14  2012 Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya. ---
15  2012 S-phase fraction and ploidy as predictive markers in primary disease and recurrence of papillary thyroid carcinoma. DFS, LNM, OS, PTC, pTNM
16  2011 Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients. BrdUrdLI, MIB-1 LI, RT, RV
17  2011 Ploidy and S-phase fraction as predictive markers of response to radiotherapy in cervical cancer. AC, AS
18  2011 The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. DI, HA, MV
19  2011 The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma. CDKs, OS, PCF
20  2010 Chromatin texture, DNA index, and S-phase fraction in primary breast carcinoma cells analysed by laserscanning cytometry. LSC
21  2010 COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. COX-2
22  2010 HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients. DI, ELISA, HLA-G, sHLA-G
23  2010 S-phase fraction and DNA ploidy in oral leukoplakia. DI
24  2010 The cell-cycle kinetics of craniopharyngioma and its clinical significance. AEs, CP, FCM, SPTs, TUNEL
25  2010 [Expression of p53 and flow cytometric analysis of DNA index and S-phase fraction in pterygium]. DI
26  2009 Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck. 18F-FDG, FISH, HNSCC, PCR-SSCP
27  2009 Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia. AA, h-MDS
28  2009 Pure mucinous carcinomas of the breast: prognostic study including DNA flow cytometry. HRs
29  2009 Serum sFas and tumor tissue FasL negatively correlated with survival in Egyptian patients suffering from breast ductal carcinoma. sFas
30  2009 Underexpression of PPARgamma is associated with aneuploidy and lower differentiation of thyroid tumours of follicular origin. PPARgamma, TSHR
31  2009 [Dendritic cell-tumor cell fusion vaccine prevents growth of subcutaneous transplanted esophageal carcinomas]. CTLs, DC, LI, PCNA, PEG
32  2009 [The Correlation between FDG PET/CT Imaging and Molecule Makers in Non-Small Cell Lung Cancer.]. FDG, GLUT1, NSCLC, PCNA, SUV, VEGF
33  2008 Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma. ATC
34  2008 Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial. DI, TH
35  2008 Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer. AUC, CI, HR, pT, TATI
36  2008 Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival. LI, MeFS, OS
37  2008 Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors. DI
38  2008 Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma. ---
39  2008 S-phase fraction as a useful marker for prognosis and therapeutic response in patients with aplastic anemia. AA
40  2008 S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. DFS, FNA, OS, SAR
41  2008 Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer. DDFS, NNBC, PAI-1, PgR, uPA, VEGF
42  2007 Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. bFGF, hK2, NAF, PND, PSA
43  2007 Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast. IDC, LN, PCNA
44  2007 DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study. FC, GC
45  2007 Expression and significance of glucocorticoid receptor alpha in meningiomas. GRalpha, PI
46  2007 The effect of the ionic products of Bioglass dissolution on human osteoblasts growth cycle in vitro. DMEM, PI
47  2007 [DNA ploidy and proliferative activity in salivary gland tumours]. ---
48  2007 [Influence of SEPT7 on biological characters of glioma cell line TJ905]. ---
49  2007 [Reevaluation resection margin rectal cancer by flow cytometry and pathological examination]. DI, PI, TME
50  2006 DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer. DFS, ER, OS
51  2006 Early apoptotic responses in transgenic mouse mammary carcinoma for photodynamic therapy. PDT, TDI
52  2006 Flow cytometric S-phase fraction contributes to diagnosis of diploid malignant salivary gland tumours. ---
53  2006 TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma. LSCC
54  2005 5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent. 5-HTT, ERKs, FCM, FITC, MTT, ODN, PASMCs, PI
55  2005 An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor. EGFR, siRNA
56  2005 Association of DNA pattern of metastatic lymph node with disease free survival in patients with intraoral squamous cell carcinoma. OSCC
57  2005 Cellular DNA content parameters as prognostic indicators in human astrocytomas. CDCP, DNA-A, DNA-D
58  2005 Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. DFS, DIP, LCR, MFS, OS
59  2005 Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer. ---
60  2005 Dilution effect of nontumor cells on flow cytometric DNA S-phase fraction in breast cancer fine needle aspirates. ---
61  2005 DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma. LN
62  2005 Ductal breast carcinomas with whole chromosome gains as a particular subset of near-diploid tumors with different metastasis free survival. DI
63  2005 Prognostic significance of DNA quantification by flow cytometry in ovarian tumors. ---
64  2005 S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. ---
65  2005 Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. VEGF, vWF
66  2005 [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. DFS, DIP, LCR, MFS, OS
67  2005 [Flow cytometry-pathology combined study of breast cancer]. DI, ER, mtp53
68  2004 Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. CCND1, FCM, FISH, SCCHN
69  2004 Analysis of correlation between mitotic index, MIB1 score and S-phase fraction as proliferation markers in invasive breast carcinoma. Methodological aspects and prognostic value in a series of 257 cases. DFS, MI, OS, PR
70  2004 DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma. FCM, FDG, FNA, HNSCC, ICM, MR, PET
71  2004 Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns. good
72  2004 Lipomatous hemangiopericytoma of the head and neck: immunohistochemical and DNA ploidy analyses. LHPC
73  2004 Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma. FCM, uPA
74  2004 Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy. 5-FU, CT, MI, pCR, PPBCs
75  2004 Proliferative activity in primary breast carcinomas is a salient prognostic factor. ---
76  2004 Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein. NSCLC
77  2004 [An analysis of DNA content and cell cycle in nasopharyngeal carcinoma]. NPC
78  2004 [DNA quantitative analysis of head and neck tumor]. 5c Ex, DI, PI
79  2004 [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy]. PI
80  2004 [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells]. AI, EGFR, MMP-9
81  2003 Correlation of grade of urothelial cell carcinomas and DNA histogram features assessed by flow cytometry and automated image cytometry. CV, DI, FCM, ICM, UC
82  2003 Flow cytometric analysis of aneuploidy and S-phase fraction in chronic myeloid leukemia patients: role in early detection of accelerated phase. CML
83  2003 Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. FNAC, NHL, NOS
84  2003 Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy. ---
85  2003 hTERT mRNA expression correlates with telomerase activity in human breast cancer. ER, PgR, RT-PCR, TPG, TRAP
86  2003 Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma. HCC, iNOS, MVD, PI, VEGF
87  2003 Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma. ---
88  2003 Maspin expression in invasive breast cancer: association with other prognostic factors. IBC, PR
89  2003 Oestrogen and progesterone receptor expression influences DNA ploidy and the proliferation potential of breast cancer cells. ICM, PgR
90  2003 Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients. FNAC
91  2003 Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. B-MALT, DLBCL, PCNA
92  2003 Prognostic value of S-phase fraction in 920 breast cancer patients: focus on T1N0 status. HR, HR
93  2003 S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study. DFS
94  2003 Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome. AF
95  2003 Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. DFI, ER, PgR
96  2003 [Preoperative hyperfractionated accelerated irradiation-induced apoptosis in non-small cell lung cancer]. AI, FI, HART
97  2003 [The diagnostic value of FCM DNA content and S-phase fraction in bronchial biopsy specimen for lung cancer]. DI, FCM
98  2002 Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer. CT, NSCLC
99  2002 Can flow cytometrically determined DNA ploidy and S-phase fraction predict regional metastasis in squamous cell carcinoma of the oral cavity? ---
100  2002 Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. TK